Rare and Genetic Kidney Disease Drug Development Summit
Evvnt Promotion / evvnt
Archive
30.11.2021 - 02.12.2021 Online
Time: 10:00 am - 5:30 pm
Conference themes
Marrying unmissable insights from global renal experts, the 1st Rare and Genetic Kidney Disease Drug Development Summit is uniquely positioned to provide you with transformative perspectives from identifying genetic drivers of rare kidney diseases to innovative trial design in small disease populations to accelerate progress of your genetic kidney disease pipeline.
Marrying unmissable insights from global renal experts, the 1st Rare and Genetic Kidney Disease Drug Development Summit is uniquely positioned to provide you with transformative perspectives from identifying genetic drivers of rare kidney diseases to innovative trial design in small disease populations to accelerate progress of your genetic kidney disease pipeline.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Notes
Brochure: https://go.evvnt.com/853526-3?pid=4832
Speakers: Alan Glicklich, Chief Medical Officer, Chinook Therapeutics, Alex Bell, Director Kidney Disease Drug Discovery, Ionis Pharmaceuticals and more
Brochure: https://go.evvnt.com/853526-3?pid=4832
Speakers: Alan Glicklich, Chief Medical Officer, Chinook Therapeutics, Alex Bell, Director Kidney Disease Drug Discovery, Ionis Pharmaceuticals and more
Enquiries and Registration:
https://go.evvnt.com/853526-1?pid=4832
Ms. Emily Birt
General Medicine
Languages
English
English
Congress fees
USD 1899.00 - USD 3397.00
USD 1899.00 - USD 3397.00
Participants expected
1000
1000
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
